Prion pathogenesis in the absence of NLRP3/ASC inflammasomes

Mario Nuvolone1, Silvia Sorce1, Petra Schwarz1

  • 1Institute of Neuropathology, University Hospital of Zurich, Zurich, Switzerland.

Plos One
|February 12, 2015
PubMed

Insights

The NLRP3 inflammasome is not essential for prion disease progression or pathology in mice. Genetic deletion of NLRP3 or ASC did not alter scrapie incubation times or IL-1β levels, challenging therapeutic targeting.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Prion diseases involve the accumulation of misfolded prion proteins (PrPSc) and microglia activation in the central nervous system.
  • The NLRP3 inflammasome, crucial for IL-1β release, was previously implicated in prion-related inflammation in vitro.
  • Its role in prion disease pathogenesis in vivo remained uninvestigated.

Purpose of the Study:

  • To investigate the role of the NLRP3 inflammasome and its adaptor ASC in prion disease pathogenesis using a mouse model.
  • To determine if NLRP3 inflammasome components are essential for disease progression and neuroinflammation.

Main Methods:

  • Intracerebral inoculation of scrapie prions (strain RML) into wild-type, Nlrp3-/-, and Pycard-/- mice.
  • Monitoring of scrapie attack rates and incubation times.
  • Histological and biochemical analysis of brain tissue, including IL-1β quantification.

Main Results:

  • Mice lacking NLRP3 or ASC exhibited similar scrapie susceptibility and incubation periods compared to wild-type controls.
  • Genetic ablation of NLRP3 or ASC did not significantly affect the classic features of prion disease.
  • Brain IL-1β levels at the terminal stage of disease were not significantly impacted by the absence of NLRP3 or ASC.

Conclusions:

  • The NLRP3 inflammasome and ASC are not critical for prion disease pathogenesis in this mouse model.
  • These findings suggest that NLRP3 and ASC are unlikely to be effective therapeutic targets for prion diseases.
  • The study refutes the claimed in vitro findings regarding the essential role of NLRP3 in prion disease.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
13.2K
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
2
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.7K
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
3
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
3
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.3K